Speaking to this, it is possible that different tumor types that are prevalent in TSC patients, as well as those that define LAM disease, are derived from TSC1- or TSC2-deficient cells of different neural crest subtypes. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.